TRBCX (TRBCX) Stock Price & Analysis
TRBCX (TRBCX) fell 0.58% to USD 203.25 as of July 26, 2026 at 00:27 UTC, according to Nexqual real-time market data.
TRBCX last closed at USD 204.44; the session ranged USD 203.25–203.25 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 179.68–227.75 (NAS). Source: Nexqual, July 26, 2026 at 00:27 UTC.
Key Statistics (as of July 26, 2026 at 00:27 UTC)
| Price | USD 203.25 |
|---|---|
| Change | ▼ 0.58% (down) |
| Previous Close | USD 204.44 |
| Open | USD 203.25 |
| Day Range | USD 203.25 – 203.25 |
| 52-Week Range | USD 179.68 – 227.75 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (TRBCX)
Nexqual's technical model rates TRBCX "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 00:27 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 39.88 (neutral) |
| vs SMA50 | Below (USD 212.75) |
| MACD | -1.41 (negative) |
Financial Health Score (TRBCX)
Nexqual rates TRBCX's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 00:27 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RPMGX | T. Rowe Price Mid-Cap Growth Fu | USD 98.52 | ▼ 0.53% |
| PRHSX | T. Rowe Price Health Sciences F | USD 90.29 | ▲ 1.27% |
| PRFDX | T. Rowe Price Equity Income Fd | USD 44.73 | ▲ 0.22% |
| PRSCX | T. Rowe Price Science and Techn | USD 68.7 | ▼ 2.54% |
| PRNHX | T. Rowe Price New Horizons Fund | USD 57.37 | ▼ 1.27% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 00:27 UTC. This page is informational and not investment advice.